Noctura 400 is a treatment for diabetic eye disease developed by UK company, PolyPhotonix.
Noctura 400 has been developed for the treatment and prevention of Diabetic Retinopathy. It is a home-based, non-invasive, monitored treatment, which can be used earlier or in parallel with the current treatments such as laser photocoagulation and intravitreal injections.
It is available through ophthalmologists or approved high street and home visiting opticians.
